Saleh bin Mohamed Hamad Al-Hammadi
Vorsitzender bei Aziz Contracting & Industrial Investment Co.
Vermögen: 311 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Saleh bin Mohamed Hamad Al-Hammadi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aziz Contracting & Industrial Investment Co.
 Aziz Contracting & Industrial Investment Co. Engineering & ConstructionIndustrial Services Aziz Contracting & Industrial Investment Co. engages in constructing wastewater treatment plants and water transmission systems. The company was founded in 1967 and is headquartered in Riyadh, Saudi Arabia.
2
| Private Company | Engineering & Construction | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Saleh bin Mohamed Hamad Al-Hammadi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Weber State University | College/University | Undergraduate Degree | |
| SAUDI AUTOMOTIVE SERVICES COMPANY | Specialty Stores | Chairman | |
| SAUDI CHEMICAL HOLDING COMPANY | Industrial Specialties | Director/Board Member | |
| AL-BAHA INVESTMENT AND DEVELOPMENT COMPANY | Real Estate Development | Chairman | |
| Saudi Organization of Certified Public Accountant | Corporate Officer/Principal | ||
| Saudi Economics Association | Corporate Officer/Principal | ||
| EAST PIPES INTEGRATED COMPANY FOR INDUSTRY | Steel | Director/Board Member | |
Al Hammadi Hospital
 Al Hammadi Hospital Hospital/Nursing ManagementHealth Services Part of Al Hammadi Holding, Al Hammadi Hospital operates a hospital. The company is based in Olaya, Saudi Arabia. | Hospital/Nursing Management | Chairman | |
Sudair Pharmaceutical Co.
 Sudair Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Sudair Pharmaceutical Co. is a pharmaceutical company based in Saudi Arabia. Sudair Pharmaceutical has a diversified portfolio that includes targeted therapy, immuno-modulators, and classic chemotherapy for the management of more than 9 tumor types. The Saudi Arabian company is committed to drug safety and pharmacovigilance, and is constantly listening to its customers to improve its products. The private company was founded in 2014 by Yasser AlObaida, who has been the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
| Support Medical Support Ltd. Co. | Chief Executive Officer | ||
| Pharma Serve Ltd. Co. | Chief Executive Officer | ||
| Medical Industrial Co. Ltd. | Director/Board Member | ||
| Construction & Maintenance Co.(SA) | Chief Executive Officer | ||
| Al Hammadi Information Technology Co. | Director/Board Member | ||
| AL HAMMADI HOLDING COMPANY | Hospital/Nursing Management | Chief Executive Officer |
Statistik
International
| Saudi-Arabien | 15 |
| Vereinigte Staaten | 2 |
Sektoral
| Health Services | 3 |
| Consumer Services | 2 |
| Retail Trade | 2 |
| Process Industries | 2 |
| Finance | 2 |
Operativ
| Director/Board Member | 9 |
| Chief Executive Officer | 4 |
| Chairman | 3 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Saleh bin Mohamed Hamad Al-Hammadi
- Unternehmensverbindungen
